Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients.
Laura GaleottiFrancesco CeccheriniCarmen FucileValeria MariniAntonello Di PaoloNatalia MaximovaFrancesca MattioliPublished in: Pharmaceutics (2021)
The population pharmacokinetic model described the interindividual variability and identified Ctrough threshold values that were predictive of hepatic/renal and hematological toxicities associated with DFX.
Keyphrases